21 Jan 2013, BioSpectrum Bureau , BioSpectrum
Singapore: DaVita, the kidney care division of US-based DaVita HealthCare Partners and a leading provider of kidney care services, has formed a joint venture with Riches Healthcare (RHC), through which a new entity, DaVita Taiwan. DaVita will own a majority share of the joint venture entity.
"Expanding our presence into Taiwan is a key step in our long-term growth strategy in Asia," said Mr Dennis Kogod, chief operating officer, DaVita.
The four clinics, which are currently serviced by RHC, are located in and around Taipei and have a combined number of 88 stations. They are providing hemodialysis treatments to more than 250 patients.
"This acquisition is an exciting opportunity not only to expand into Taiwan, but also to do so with a well-respected and highly experienced team," said Mr Atul Mathur, president, Asia Pacific, DaVita. "With the addition of this JV, DaVita is now serving patients in five countries across the Asia Pacific region."
As a leading provider of kidney care services in the US, DaVita has achieved clinical outcomes that have improved year-over-year for more than a decade and plans to bring that track record of sustained clinical excellence to Taiwan.